• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge

tetano

Editor, Senior Moderator
NPJ Vaccines. 2018 Jul 3;3:25. doi: 10.1038/s41541-018-0063-7. eCollection 2018.
[h=1]Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge.[/h] van der Lubbe JEM[SUP]1[/SUP], Huizingh J[SUP]1[/SUP], Verspuij JWA[SUP]1[/SUP], Tettero L[SUP]1[/SUP], Schmit-Tillemans SPR[SUP]1[/SUP], Mooij P[SUP]2[/SUP], Mortier D[SUP]2[/SUP], Koopman G[SUP]2[/SUP], Bogers WMJM[SUP]2[/SUP], Dekking L[SUP]1[/SUP], Meijberg W[SUP]1,[/SUP][SUP]3[/SUP], Kwaks T[SUP]1[/SUP], Brandenburg B[SUP]1[/SUP], Tolboom JTBM[SUP]1[/SUP], Schuitemaker H[SUP]1[/SUP], Roozendaal R[SUP]1[/SUP], Kuipers H[SUP]#[/SUP][SUP]1[/SUP], Zahn RC[SUP]#[/SUP][SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Seasonal vaccines are currently the most effective countermeasure against influenza. However, seasonal vaccines are only effective against strains closely related to the influenza strains contained in the vaccine. Recently a new hemagglutinin (HA) stem-based antigen, the so-called "mini-HA", has been shown to induce a cross-protective immune response in influenza-naive mice and non-human primates (NHP). However, prior exposure to influenza can have a profound effect on the immune response to subsequent influenza infection and the protective efficacy of vaccination. Here we show that mini-HA, compared to a trivalent influenza vaccine (TIV), elicits a broadened influenza-specific humoral immune response in NHP previously exposed to influenza. Serum transfer experiments showed that antibodies induced by both mini-HA and seasonal vaccine protected mice against lethal challenge with a H1N1 influenza strain heterologous to the H1 HA included in the TIV. However, antibodies elicited by mini-HA showed an additional benefit of protecting mice against lethal heterosubtypic H5N1 influenza challenge, associated with H5 HA-specific functional antibodies.


PMID: 29977611 PMCID: PMC6030213 DOI: 10.1038/s41541-018-0063-7
Free PMC Article
 
Back
Top Bottom